AVALON GLOBOCARE CORP. (ALBT) Return on equity 2016–2024
AVALON GLOBOCARE CORP. (ALBT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-111.3%FY2024 · since FY2016: 1.6% → -111.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -111.3% | +115.5 pp |
| FY2023 | -226.7% | -119.8 pp |
| FY2022 | -106.9% | +187.8 pp |
| FY2021 | -294.7% | +13.3 pp |
| FY2020 | -308.0% | +96.7 pp |
| FY2019 | -404.7% | -333.1 pp |
| FY2018 | -71.6% | -20.3 pp |
| FY2017 | -51.3% | -52.9 pp |
| FY2016 | 1.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice